SC
ARNA

Sculptor Capital’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Sculptor Capital’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-13,960
Closed -$817K – 835
2013
Q4 		$817K Buy
13,960
+4,500
+48% +$235K ﹤0.01% 686
2013
Q3 		$499K Buy
+9,460
New +$635K ﹤0.01% 673
2013
Q2 		– Hold
0
– – – 683

Other funds holding ARNA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Sculptor Capital's ARNA Position: Q1 2014 in Review

Sculptor Capital sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2014, closing a stake of 13,960 shares — an estimated $817K sold.

Sculptor Capital first reported a position in ARNA in Q3 2013 and held it in 2 quarters. The position peaked at $817K in Q4 2013. 131 funds tracked by Wall St. Rank hold ARNA as of Q1 2014.

  • Sculptor Capital reported no remaining Arena Pharmaceuticals Inc position as of Q1 2014 after selling out during the quarter.
  • Sculptor Capital sold 13,960 Arena Pharmaceuticals Inc shares in Q1 2014, an estimated $817K.
  • Sculptor Capital first reported a position in Arena Pharmaceuticals Inc in Q3 2013 and held it in 2 quarters.
  • Sculptor Capital's Arena Pharmaceuticals Inc position peaked at $817K in Q4 2013.
  • 131 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2014.

Based on Sculptor Capital's 13F filing for Q1 2014, filed 15 May 2014.